MétaCan
Menu
Back to cohort
Record W6980416583

Campaign manufacturing of highly active pr sensitising ingredients: a comparison between the GMPs of various regulatory agencies

2019· article· en· W6980416583 on OpenAlexaboutno aff

Bibliographic record

VenueUnicam Scientific Publications (University of Camerino) · 2019
Typearticle
Languageen
FieldMedicine
TopicPharmacological Effects of Medicinal Plants
Canadian institutionsnot available
Fundersnot available
KeywordsProduction (economics)HarmonizationOrder (exchange)Certification
DOInot available

Abstract

fetched live from OpenAlex

INTRODUCTION
\nHighly active or sensitising ingredients (API/SI) need special rules for their production. Cross-contamination and mix-ups represent the greatest dangers related to the manufacturing of API/SI.
\nThese risks are obviously greater in campaign manufacturing (CM) and therefore this type of production can only be performed using certified procedures able to guarantee non residue between the two different processes.
\n
\nNevertheless, as there is no global harmonization of GMPs, some nations require particular working conditions for manufacturing given products, while other countries require different ones. In this paper we have studied the problems related to the CM of API/SI under the different Regulatory Authorities, by analyzing and comparing their Good Manufacturing Practices (GMPs).
\n
\nMETHODS
\nWe studied the GMPs of the different Regulatory Agencies (EMA, CFDA, COFEPRIS, FDA, Health Canada, ANVISA, CDSCO, PIC/S, and WHO) in order to assess which Authorities allow CM for the production of the following categories of drugs: hormones, immunosuppressants, cytotoxic agents, API, biological preparations, steroids, antibiotics, cephalosporins, penicillin, carbapenems, beta-lactam derivatives.
\n
\nRESULTS
\nThe rules of the Regulatory Agencies we studied (regarding the production of API/SI) can be divided into three types: 
\n1) CM is permitted only where adequate technical/organisational measures are used as well as adequate cleaning measures that can guarantee the safety of the method: Health Canada, EMA, PIC/S, FDA.
\n2) CM is permitted for the production of certain classes of API/SI only in exceptional circumstances: CFDA, WHO, ANVISA. CFDA and WHO allow CM only for the production of “certain” API and in exceptional circumstances (without defining in the regulations which circumstances can be defined as exceptional). ANVISA allows the use of CM only in the case of serious emergencies (i.e.: war, fires, floods).
\n3) CM is not provided or mentioned: COFEPRIS, CDSCO.
\n
\nCONCLUSIONS
\nSignificant differences emerged between the GMPs Regulatory Authorities both as regards the classes of drugs that can be produced through CM and as regards the Agencies that authorize it.
\nThe pharmaceutical industry, in deciding which drugs can be produced according to the principles of CM, will have to use a Quality Risk Management and choose this production method only where the Regulatory Authority allows it and where there are procedures that can guarantee the elimination of the risk of cross-contamination.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.753
Threshold uncertainty score0.504

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.262
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueUnicam Scientific Publications (University of Camerino)Same topicPharmacological Effects of Medicinal PlantsFrench-language works237,207